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Marchigian Sardinian alcohol-preferring (msP) rats exhibit innate preference for alcohol, are
highly sensitive to stress and stress-induced alcohol seeking. Genetic analysis showed
that over-expression of the corticotropin-releasing factor (CRF) system of msP rats is cor-
related with the presence of two single nucleotide polymorphisms (SNPs) occurring in
the promoter region (position −1836 and −2097) of the CRF1 receptor (CRF1-R) gene.
Here we examined whether these point mutations were associated to the innate alcohol
preference, stress-induced drinking, and seeking. We have recently re-derived the msP
rats to obtain two distinct lines carrying the wild type (GG) and the point mutations (AA),
respectively. The phenotypic characteristics of these two lines were compared with those
of unselected Wistar rats. Both AA and GG rats showed similar patterns of voluntary alco-
hol intake and preference. Similarly, the pharmacological stressor yohimbine (0.0, 0.625,
1.25, and 2.5 mg/kg) elicited increased operant alcohol self-administration under fixed and
progressive ratio reinforcement schedules in all three lines. Following extinction, yohim-
bine (0.0, 0.625, 1.25, and 2.5 mg/kg) significantly reinstated alcohol seeking in the three
groups. However, at the highest dose this effect was no longer evident in AA rats. Treat-
ment with the CRF1-R antagonist antalarmin (0, 5, 10, and 20 mg/kg) significantly reduced
alcohol-reinforced lever pressing in the AA line (10 and 20 mg/kg) while a weaker or no
effect was observed in the Wistar and the GG group, respectively. Finally, antalarmin sig-
nificantly reduced yohimbine-induced increase in alcohol drinking in all three groups. In
conclusion, these specific SNPs in the CRF1-R gene do not seem to play a primary role
in the expression of the msP excessive drinking phenotype or stress-induced drinking
but may be associated with a decreased threshold for stress-induced alcohol seeking and
an increased sensitivity to the effects of pharmacological blockade of CRF1-R on alcohol
drinking.
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INTRODUCTION
Alcoholism is an etiologically and clinically heterogeneous disor-
der in which compulsive alcohol use and elevated vulnerability to
relapse represent core symptoms (McLellan et al., 1992). Expo-
sure to alcohol is a necessary precondition for development of
alcoholism. However, environment and heritability factors play a
dramatic role in controlling individual predisposition to devel-
oping alcohol abuse (Cloninger et al., 1981; Schuckit et al., 1985;
Enoch and Goldman, 1999; Lovinger and Crabbe, 2005). Environ-
mental stress has been recognized as one of the major factors for
alcohol abuse and dependence (Pohorecky, 1991; Sarnyai et al.,
2001; Sinha, 2001; Shaham et al., 2003; Breese et al., 2005b). How-
ever, the interaction between environmental stress and heritable
factors in the development of alcoholism is still largely unexplored.
Understanding the nature of this interaction in regulating indi-
vidual risk of becoming an alcohol abuser represents a major
challenge in this research field and may provide invaluable help for
the development of preventive strategies or pharmacotherapeutic
remedies.
Studies conducted in our laboratory demonstrated that geneti-
cally selected Marchigian Sardinian alcohol-preferring (msP) rats
show excessive daily alcohol drinking (6–8 g/kg body weight) in a
binge-type pattern, leading to blood alcohol levels as high as 100–
120 mg/dl (Ciccocioppo et al., 2006). This selected rat line is highly
sensitive to stress and stress-induced alcohol seeking (Ciccocioppo
et al., 2006), demonstrates an anxious phenotype (Hansson et al.,
2006), and has depressive-like symptoms that recover following
alcohol consumption (Ciccocioppo et al., 1999). Hence, these
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animals may represent a preclinical model of genetic predisposi-
tion to high alcohol drinking and relapse endowed with significant
predictive validity. In addition, msP rats appear to share impor-
tant common characteristics with the human disease that also
confer to them important elements of face and construct validity
(Ciccocioppo et al., 2006; Ciccocioppo, 2013).
The corticotropin-releasing factor (CRF) is a 41 amino acid
peptide that integrates many of the endocrine, behavioral, and
autonomic responses to stress (Sarnyai et al., 2001). CRF has been
implicated in alcohol addiction because there is evidence that neu-
roadaptive changes triggered by a prolonged history of alcohol
exposure lead to a chronically dysregulated CRF/CRF1 receptor
(CRF1-R) system activity that, in turn may drive excessive and
uncontrolled alcohol consumption motivated by relief of neg-
ative emotionality (Heilig and Koob, 2007; Koob, 2010; Breese
et al., 2011). In particular, upregulation of the peptide has been
observed in the extended amygdala during alcohol withdrawal
(Merlo Pich et al., 1995; Zorrilla et al., 2001; Olive et al., 2002;
Roberto et al., 2010) and long-term upregulation of CRF1-Rs has
been also shown in these structures in animals with a previous his-
tory of alcohol dependence (Sommer et al., 2008). Similarly, msP
animals show innate upregulation of CRF1-R expression and den-
sity in multiple corticolimbic regions, indicating hyperfunction of
the CRF system (Hansson et al., 2006), which is attenuated by alco-
hol consumption (Hansson et al., 2007). In agreement with these
findings, both alcohol-induced neuroadaptations leading to dys-
regulated CRF system and the innate hyperfunction of the system
in msP rats have been shown to confer sensitivity to the treatment
with CRF1-R antagonists. Core symptoms of alcohol dependence
including excessive alcohol self-administration and stress-induced
relapse to alcohol seeking were in fact attenuated at doses that
had no effects in non-dependent unselected animals (Funk et al.,
2006a; Hansson et al., 2006; Sabino et al., 2006; Gehlert et al., 2007;
Ciccocioppo et al., 2009). All these similarities suggest that innate
upregulation of CRF1-R expression mimics the post-dependent
phenotype such that msP rats have been proposed as phenocopies
of post-dependent animals (Heilig and Koob, 2007).
Further work done in msP rats provided evidence that excessive
alcohol drinking and stress vulnerability may be associated with
the occurrence of two single nucleotide polymorphisms (SNPs)
in the promoter region (position −1836 and −2097) of the gene
encoding the CRF1 receptor, an observation that closely correlated
with innate upregulation of the CRF1-R transcript (Hansson et al.,
2006). Genetic variation at the CRF1-R locus as a susceptibility fac-
tor for excessive alcohol drinking might have parallels in humans,
where a similar association was reported (Treutlein et al., 2006).
It is, however, unclear whether the −1836 and −2097 SNPs are
causally related to escalated alcohol consumption. Of note, high
alcohol preference is a complex trait, and may be driven by dif-
ferent genetic factors in different genetically selected preferring
lines. These SNPs are unique to msP animals, and genetic screen-
ing in the Indiana alcohol-preferring [P (Li et al., 1991)] and the
Sardinian alcohol-preferring [sP (Colombo et al., 1995)] indicates
that these lines do not carry mutations at the CRF1-R locus (oral
communication).
Here, we tested whether the occurrence of the SNPs is respon-
sible for the high alcohol drinking and preference of msP rats and
whether the occurrence of the point mutations may contribute to
other behavioral differences including sensitivity to the treatment
with CRF1-R antagonist and relapse susceptibility. To assess how
environmental stress interacts with heritable factors, rats were re-
derived from the original msP line to obtain two distinct lines,
one carrying the two point mutations (AA) and the wild type line
(GG). The phenotypic characteristics of these two msP rat lines
were assessed following stress exposure and compared with those
of unselected Wistar rats.
MATERIALS AND METHODS
ANIMALS
Subjects were adult males from two distinct sub-lines derived from
the original msP line (65th generation). Animals were bred at
the animal facility of the University of Camerino, Italy. Breeding
started following genetic screening of the promoter region encod-
ing for CRF1-Rs. Sequence variation AA versus GG in position
−1836 and −2097 respectively, of the CRF1-R transcript distin-
guished the two msP lines. Specifically, 80 msP rats were sequenced
using Taqman-PCR analysis of tail DNA to identify animals car-
rying (AA) or not carrying (GG) both variants. The homozygous
male and female AA and GG were then bred to obtain re-derived
lines selectively carrying the AA and the GG types. They were bred
for two more generations and then animals from the third and
fourth generations were used for experiments. Male Wistar rats
(Charles River, Calco, Italy) were employed as a behavioral control.
All rats (350–450 g) at the time of the experiments were housed
in groups of five or four except where otherwise specified, on a
reverse 12 h light-dark cycle (lights off at 08:30 AM) at a constant
temperature of 20± 2˚C and relative humidity of 45–55%, with
free access to tap water and food pellets (4RF18, Mucedola, Set-
timo Milanese, Italy). Animals were handled three times before the
onset of each experiment. All procedures followed theEUDirective
for Care and Use of Laboratory Animals.
DRUGS
Alcohol solution (10% v/v) was prepared by diluting 95% alcohol
(F.L. Carsetti s.n.c.-Camerino) in tap water. The selective CRF1-
R antagonist antalarmin (N -butyl-N -ethyl-[2,5,6-trimethyl-7-
(2,4,6-trimethylphenyl)-7H -pyrrolo[2,3-d]pyrimidin4-yl]-amine
(Webster et al., 1996) was obtained from the National Institute
on Alcohol Abuse and Alcoholism (NIAAA/NIH). Antalarmin
was suspended in a vehicle composed of 10% Tween 80 and
distilled water and given intraperitoneally (i.p.) in a 1 ml/kg vol-
ume injection. Yohimbine hydrochloride (17-hydroxyyohimban-
16-carboxylic acid methyl ester hydrochloride) was purchased
from Sigma (Sigma-Aldrich, Italy) and dissolved in distilled water.
Yohimbine was administered i.p. in a 1 ml/kg volume injection.
Physiological saline was injected three times prior to drug testing
for habituation to the experimental procedures.
TWO-BOTTLE FREE CHOICE DRINKING PARADIGM
To ascertain the relation of CRF1-R promoter genotype to home
cage alcohol intake, AA (n= 8) and GG (n= 8) msP rats were
used and their intake measured daily. Rats were single-housed
to provide accurate record of home cage drinking. Animals were
provided ad libitum concurrent, continuous access to 10% alco-
hol solution, water, and food pellets. Fluids were presented in
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graduated plastic bottles equipped with a stainless-steel drink-
ing spouts inserted through two grommets in front of the cage
and were changed daily at 90–120 min into the dark period of the
light/dark cycle. The placement of the alcohol bottle was alternated
daily to control for side preference. This procedure was carried out
for 15 days. Data are presented as daily alcohol intake (g/kg) and
percentage of alcohol preference [100× alcohol intake (ml)/total
fluid intake (ml)].
OPERANT SELF-ADMINISTRATION APPARATUS AND TRAINING
Training and testing were conducted in operant conditioning
chambers housed in sound-attenuating cubicles (Med Associates
Inc., Georgia,VT, USA). Each operant chamber was equipped with
two retractable levers positioned laterally to a drinking reservoir.
Visual stimuli were presented via a light located on the back panel.
A microcomputer controlled the delivery of the fluids, presenta-
tion of visual stimuli, and recording of the behavioral data. Rats
were trained to self-administer 10% alcohol (v/v) in 30 min daily
sessions on a fixed ratio 1 (FR-1) schedule of reinforcement, in
which each response on the active lever resulted in delivery of
0.1 ml of fluid. A response on the second lever had no programed
consequences. For the first 3 days, rats were allowed to lever-press
for a 0.2% (w/v) saccharin solution, and were then trained to self-
administer 10% alcohol by gradually increasing the percentage of
alcohol and fading out the saccharin (Cippitelli et al., 2008).
OPERANT ALCOHOL SELF-ADMINISTRATION ON A FIXED RATIO 3
SCHEDULE OF REINFORCEMENT FOLLOWING STRESS EXPOSURE
Rats (n= 34; 10 Wistars, 14 GG, and 10 AA msPs) were trained
to self-administer 10% alcohol as described above. When all the
rats reached the 10% alcohol stage, the schedule of reinforce-
ment was changed from FR-1 to FR-3. Here, following three
responses that delivered a reinforcer, a 5-s time-out period was
in effect, during which responses were recorded but not rein-
forced. Once stable self-administration responding was obtained
under this reinforcement schedule, the experiment was started.
Stress exposure consisted of the challenge with the pharmaco-
logical stressor yohimbine at doses previously shown to increase
alcohol-reinforced lever pressing in unselected Wistar animals
(Marinelli et al., 2007). Yohimbine (0.0, 0.625, 1.25, and 2.5 mg/kg)
was administered 30 min prior to the 30 min self-administration
session. The experiment was conducted in parallel for the three
rat lines using a Latin square counterbalanced within-subjects
design. Test sessions were 4 days apart. Following each test session
day, animals were allowed 1 day off, and a new baseline was then
established over the following 2 days as previously reported (Cip-
pitelli et al., 2010b). Results are described as number of rewards in
30 min.
OPERANT ALCOHOL SELF-ADMINISTRATION ON A PROGRESSIVE
RATIO SCHEDULE OF REINFORCEMENT FOLLOWING STRESS EXPOSURE
Additional rats (n= 30; 10 Wistars, 10 GG and 10 AA msPs) were
trained to self-administer 10% alcohol. When all the rats reached
the 10% alcohol stage, the schedule of reinforcement was changed
from FR-1 to FR-3. As described above, following three responses
that delivered a reinforcer, a 5-s time-out period was in effect, dur-
ing which responses were recorded but not reinforced. Once stable
self-administration responding was obtained under this reinforce-
ment schedule, the three rat lines were tested under a progressive
ratio (PR) schedule of reinforcement to measure the break point,
defined as the last ratio completed by the animal (Cippitelli et al.,
2007; Karlsson et al., 2012), to obtain 10% alcohol following stress
exposure. For this purpose, the response requirement (i.e., the
number of lever responses or the ratio required to receive one
dose of 10% alcohol) was increased as follows: for each of the first
four alcohol deliveries the ratio was increased by 1; for the next
four deliveries the ratio was increased by 2 and for all of the follow-
ing deliveries the ratio was increased by 4. Each alcohol-reinforced
response resulted in the house light being turned on for 1 s,whereas
sessions were terminated when more than 30 min had elapsed since
the last reinforced response. The experiment was conducted in par-
allel for the three rat lines using a Latin square counterbalanced
within-subjects design. The pharmacological stressor yohimbine
at the dose of 0.625 mg/kg or its vehicle were administered 30 min
prior to PR testing. Test sessions were 4 days apart. Following each
test session day, animals were allowed 1 day off, and a new baseline
was then established over the following 2 days.
OPERANT ALCOHOL SELF-ADMINISTRATION ON FR-3 SCHEDULE:
EFFECT OF ANTALARMIN
Other rats (n= 33; 7 Wistars, 12 GG and 14 AA msPs) were trained
to self-administer 10% alcohol as described above. Schedule of
reinforcement was switched from FR-1 to FR-3. Following three
responses that delivered a reinforcer, a 5-s time-out period was
in effect, during which responses were recorded but not rein-
forced. Once stable self-administration was obtained under the
FR-3 reinforcement schedule, treatment with the CRF1-R antag-
onist antalarmin was started. The experiment was conducted by
using a Latin square counterbalanced design. Antalarmin at doses
of 5, 10, and 20 mg/kg or its vehicle were administered 30 min prior
to sessions. Test sessions were 4 days apart. Following each test ses-
sion day, animals were allowed 1 day off, and a new baseline was
then established over the following 2 days. Results are described as
number of rewards in 30 min.
EFFECT OF ANTALARMIN ON YOHIMBINE-INDUCED INCREASE OF
ALCOHOL-REINFORCED LEVER PRESSING (FR-3)
A new cohort of rats (n= 33; 8 Wistars, 10 GG and 15 AA msPs)
was trained to self-administer 10% alcohol as described above.
When stable baseline of responding was obtained under the FR-3
reinforcement schedule that included the 5 s time-out period, drug
treatment started. In this experiment, we pre-treated the three
rat lines either with the selective CRF1-R antagonist antalarmin
or its vehicle prior to the injection of yohimbine (0.625 mg/kg)
or yohimbine vehicle. Pre-treatments were given 30 min prior to
treatments that in turn occurred 30 min prior to testing sessions.
These testing sessions were conducted every fourth day using a
Latin square counterbalanced design and occurred 4 days apart
in which animals were allowed 1 day off, and a new baseline was
then established over the following 2 days. Results are described as
number of rewards in 30 min.
REINSTATEMENT INDUCED BY STRESS EXPOSURE
A new cohort of animals (n= 24; 7 Wistar rats, 8 GG and 9
AA msP rats) was trained at the same time to self-administer
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alcohol as described above. When 10% alcohol became available,
the FR-1 schedule slightly changed such that each lever pressing
was accompanied by the illumination of the house light for 5 s.
During this time-out period response were recorded but not rein-
forced. 10% alcohol sessions lasted 30 min and were conducted
for 15 days. Then, rats were subjected to 30 min daily extinction
sessions for additional 15 consecutive days. During extinction
the lever presses were no longer associated with alcohol delivery,
but house light was still presented to allow for its concomitant
extinction. Stress exposure consisted of the challenge with the
pharmacological stressor yohimbine at doses previously shown
to produce reinstatement to alcohol seeking in unselected Wis-
tar rats (Le et al., 2005; Marinelli et al., 2007; Cippitelli et al.,
2010a). Yohimbine (0.0, 0.625, 1.25, and 2.5 mg/kg) was admin-
istered 30 min prior to the 30 min reinstatement session that
was conducted under identical condition of extinction sessions.
A Latin square counterbalanced design was used. Test sessions
were 4 days apart and conducted after three consecutive extinc-
tion sessions. Results are described as total number of responses
in 30 min.
STATISTICAL ANALYSIS
All drug testing experiments were here analyzed by means of a
two-way analysis of variance (ANOVA) with “drug treatment” as
the within-subject factor and “rat line” as the between-subject fac-
tor. When appropriate, analyses were followed up by Fisher’s least
significant difference (LSD) post hoc tests. The same statistical
approach was employed to analyze drinking patterns of intake
and preference of GG versus AA msP rat lines with the exception
that “rat line” was the between-subject factor and “day” was used
as the within-subject factor.
RESULTS
MINIMAL CHANGES IN VOLUNTARY ALCOHOL INTAKE AND
PREFERENCE OF GG AND AA msP RATS
The GG and AA msP animals show a similar pattern of alco-
hol intake and preference over a period of 15 days as shown
in Figure 1. Overall ANOVA failed to revealed a main effect
of “line” [F(1,14)= 2.4, NS]. However, there was a main effect
of “day” [F(14,196)= 24.4, p< 0.001], accompanied by interac-
tion “line× day” [F(14,196)= 2.2, p< 0.01] to suggest minimal
changes in voluntary alcohol intake across the 15-day exposure.
Indeed, post hoc analysis showed difference in alcohol drinking
between the two msP lines only on day 6 and 13 (p< 0.001 and
p< 0.01, respectively, Figure 1A).
Data analysis of alcohol preference only showed difference in
the main effect of “day” [F(14,196)= 24.4, p< 0.01] while fail-
ing to reveal significant difference in the main effect of “line”
[F(1,14)= 2.4, NS] and interaction “line× day” [F(14,196)= 0.2,
NS]. However, a slight and non-significant trend to a higher alco-
hol preference of the AA line compared to the GG line was observed
(Figure 1B).
In a separate experiment, a different batch of the two msP lines
was subjected to a two-bottle free choice drinking across a 50 day
exposure. Results generally paralleled those shown here, that is
no major difference between lines on patterns of 10% voluntary
alcohol drinking and preference was found.
FIGURE 1 | Elevated alcohol drinking of the two msP lines GG (n= 8)
and AA (n=8) derived from the original msP line as assessed in the
two-bottle free choice drinking paradigm. GG and AA msP rats show
minimal changes in (A) drinking patterns and (B) alcohol preference across
a period of 15 days. Values are presented as the daily mean g/kg of alcohol
intake (±SEM) and percent (%) of alcohol preference (±SEM), respectively.
**p<0.01 and ***p<0.001, significant difference between the two msP
rat lines. GG: gray line; AA: black line. For detailed statistics, see “Results.”
YOHIMBINE SIMILARLY INCREASES OPERANT ALCOHOL
SELF-ADMINISTRATION UNDER A FIXED RATIO SCHEDULE OF
REINFORCEMENT IN WISTAR, AS WELL AS GG, AND AA msP RATS
Although elevated level of alcohol consumption in msP rats is
well known, overall ANOVA failed to show a main effect of
“line” [F(2,31)= 0.8, NS], indicating that under the described
experimental conditions alcohol-reinforced lever pressing was
fairly equal between groups. A clear main effect of “treatment”
[F(3,93)= 18.2, p< 0.001] that was not accompanied by a signif-
icant interaction “treatment× line” [F(6,93)= 1.5, NS] was also
revealed to suggest that exposure to pharmacological stress sim-
ilarly increased alcohol self-administration in all rat lines. On
post hoc analysis of the collapsed variable of “treatment,” yohim-
bine significantly increased the number of alcohol rewards at doses
of 0.625 (p< 0.001) and 1.25 mg/kg [(p< 0.01), Figure 2A].
YOHIMBINE SIMILARLY INCREASES BREAK POINT OF WISTAR, AS
WELL AS GG, AND AA msP RATS UNDER A PROGRESSIVE SCHEDULE OF
REINFORCEMENT
To further explore how stress exposure interacts with the genetic
background of the two msP lines, yohimbine at the dose of
0.625 mg/kg was tested on motivation to earn alcohol rewards as
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FIGURE 2 | (A) Operant alcohol self-administration in Wistar (n=10), as
well as GG (n=14), and AA (n=10) msP rats under a fixed ratio 3 (FR-3)
schedule of reinforcement is significantly increased by the systemic (i.p.)
administration of the pharmacological stressor yohimbine (0.0, 0.625, 1.25,
2.5 mg/kg) at the dose of 0.625 and 1.25 mg/kg. Values presented are the
mean number of rewards earned in 30 min (±SEM). (B) Operant alcohol
self-administration in Wistar (n=10), as well as GG (n= 10), and AA (n=10)
msP rats under a progressive ratio (PR) schedule of reinforcement is
significantly increased by the systemic (i.p.) administration of the
pharmacological stressor yohimbine at the dose of 0.625 mg/kg. Values
presented are the mean of break point measure (last ratio completed by the
animal ±SEM). **p<0.01, ***p<0.001, significant difference from the
collapsed means of vehicle-treated groups (0.0 mg/kg). Wistar: white bars;
GG: gray bars; AA: black bars. For detailed statistics, see “Results.”
assessed by the PR schedule of reinforcement paradigm. Overall
ANOVA showed a significant main effect of “line” [F(2,27)= 4.7,
p< 0.05] accompanied by a significant main effect of treatment
[F(1,27)= 23.7, p< 0.001] while interaction “treatment× line”
was not significant [F(2,27)= 0.18, NS]. As revealed by post hoc
analysis of the collapsed variable of “treatment,” these results
suggest that 0.625 mg/kg of yohimbine clearly increased the
break point measure in all three rat lines examined [(p< 0.001),
Figure 2B].
THE AA LINE IS MORE SENSITIVE THAN OTHER RAT LINES TO THE
EFFECT OF ANTALARMIN IN REDUCING ALCOHOL
SELF-ADMINISTRATION
As shown in Figure 3A, treatment with the CRF1-R antagonist
antalarmin differentially reduced alcohol-reinforced lever pressing
FIGURE 3 | (A) Dose-response curve of antalarmin (0, 5, 10, 20 mg/kg)
when systemically (i.p.) injected in Wistar (n= 7), as well as GG (n=12),
and AA (n=14) msP rats as assessed on operant alcohol self-administration
on a fixed ratio 3 (FR-3) schedule of reinforcement. The AA msP rat line
shows increased sensitivity to antalarmin treatment compared to the other
rat line examined. Data are the mean (±SEM) number of rewards earned in
30 min. **p<0.01, difference from the vehicle-treated groups (0 mg/kg).
(B) I.p. pre-treatment with antalarmin (10 mg/kg) fully blocks the escalation
of alcohol self-administration (FR-3) elicited by systemic (i.p.) treatment
with yohimbine at the dose of 0.625 mg/kg in all rat lines examined [Wistar
(n=8), as well as GG (n=10) and AA (n=15) msP rats]. Results are the
mean (±SEM) number of rewards earned in 30 min. ***p<0.001,
difference from the groups receiving both vehicle-treatments of antalarmin
and yohimbine (−/−); ###p<0.001, difference from the groups receiving
yohimbine 0.625 mg/kg (±). Wistar: white bars; GG: gray bars; AA: black
bars. For detailed statistics, see “Results.”
under FR-3 schedule. Overall ANOVA revealed a significant main
effect of treatment [F(3,90)= 7.1, p< 0.001], significant main
effect of “line” [F(2,30)= 4.5, p< 0.05] and significant interac-
tion “treatment× line” [F(6,90)= 2.5, p< 0.05]. Post hoc analysis
showed that antalarmin dose-dependently decreased lever press-
ing for alcohol in AA rats (p< 0.01 for doses of 10 and 20 mg/kg)
while being ineffective in the GG line. Dose of 20 mg/kg antalarmin
reduced the number of rewards in Wistar rats (p< 0.01).
YOHIMBINE INCREASES ALCOHOL SELF-ADMINISTRATION THROUGH
A CRF-MEDIATED MECHANISM
As shown in Figure 3B, pre-treatment with antalarmin blocked
the yohimbine-induced increase of alcohol self-administration in
all rat lines examined. Overall ANOVA showed a main effect of
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“treatment” [F(3,90)= 16.6, p< 0.001] accompanied by a main
effect of “line”[F(2,30)= 3.8,p< 0.05] with no interaction“treat-
ment× line” [F(6,90)= 1.4, NS]. In agreement with the exper-
iments described above, post hoc analysis clearly revealed that
yohimbine (0.625 mg/kg) significantly increased the number of
alcohol rewards as compared to the collapsed means of the control
groups (p< 0.001), and administration of antalarmin (10 mg/kg)
fully prevented the effect of yohimbine (p< 0.001).
YOHIMBINE AT HIGH DOSAGES FAILS TO PRODUCE REINSTATEMENT
OF ALCOHOL SEEKING IN AA msP RATS
The administration of yohimbine (0.0, 0.625, 1.25, 2.5 mg/kg)
robustly reinstated responding on the previously alcohol-
associated lever as shown by the significant main effect of “treat-
ment” [F(3,63)= 11.6, p< 0.001]. Overall ANOVA also revealed
a barely significant main effect of “line” [F(2,21)= 3.4, p= 0.05]
and lack of the interaction “treatment× line” [F(6,63)= 0.8, NS].
These results suggest that all three rat lines examined were sen-
sitive to the challenge of the pharmacological stressor. This was
confirmed by post hoc analysis on the collapsed variable of “treat-
ment” (0.625 and 1.25 mg/kg, p< 0.001; 2.5 mg/kg, p< 0.01).
However, post hoc analysis conducted on the collapsed variable
of “line” revealed that relapse-like behavior of the AA line was
different from that of both the GG msP (p< 0.05) and the Wis-
tar line (p= 0.05) following yohimbine treatment. This effect was
the result of the fact that the AA msP line failed to reinstate the
operant response following administration of 2.5 mg/kg. In con-
trast, both Wistars and GG msPs showed similar vulnerability
to the pharmacological stressor as observed with lower dosages
(Figure 4).
DISCUSSION
We found that the two msP rat lines (GG and AA) showed similar
patterns of alcohol intake and preference in the 24-h access two-
bottle free choice drinking paradigm, which was comparable to the
elevated levels of drinking previously shown by the original msP
line (Ciccocioppo et al., 2006; Hansson et al., 2007; Stopponi et al.,
2011). In addition, stress exposure elicited increased operant alco-
hol self-administration in FR-3 and PR reinforcement schedules
in both lines through a CRF1-R mediated mechanism. However,
the msP line carrying the point mutations at the CRF1-R pro-
moter region (AA) showed higher sensitivity than the wild type
line (GG) to the effects of the CRF1-R blockade by the selective
CRF1-R antagonist antalarmin. Also, the AA line showed altered
vulnerability to relapse-like behavior following pharmacological
stress exposure when compared to the GG line or to an unselected
strain such as Wistar rats.
The observation that the two derived lines showed minimal
changes in voluntary alcohol intake and preference suggests that
the occurrence of the SNPs in the CRF1-R promoter region is
not a causal genetic factor behind high alcohol intake. In oper-
ant situations, where rats work for alcohol reinforcement under
limited-access conditions, results paralleled those obtained under
unlimited 24-h voluntary alcohol access. However, in the present
study, voluntary alcohol consumption was different between sub-
lines only in 2 out of 15 days (days 6 and 13) where higher intake
was observed in the AA line. This transient increase in the amount
FIGURE 4 | Systemic (i.p.) administration of yohimbine (0.0, 0.625, 1.25,
2.5mg/kg) elicits reinstatement of alcohol seeking inWistar (n=7), as
well as GG (n=8), andAA (n=9) msP rats following extinction.The AA
msP line shows decreased threshold for yohimbine-induced reinstatement
due to different sensitivity on responding to the effects of 2.5 mg/kg
yohimbine dose. Data are the mean (±SEM) of total number of responses
in 30 min. **p< 0.01, ***p<0.001, difference from the vehicle-treated
groups (0.0 mg/kg); #p≤0.05, difference from the collapsed means of both
the GG msP and the Wistar lines. Wistar: white bars; GG: gray bars; AA:
black bars. For detailed statistics, see “Results.”
of drinking was associated with weekly cleaning of the animal
room or exchange of sawdust. Thus, either increased arousal or
heightened anxiety behavior may account for these isolated over
drinking episodes. Indeed, msP rats are known to couple elevated
alcohol consumption with comorbid anxiety which is thought to
drive excessive drinking due to self-medication and tension relief
purposes (Ciccocioppo et al., 2006; Ciccocioppo, 2013).
To test the hypothesis that stress exposure may contribute
to confer functional relevance to the polymorphism, both AA
and GG lines were exposed to pharmacological stress before
self-administering alcohol as previously shown (Le et al., 2005;
Marinelli et al., 2007). Induction of stress consisted of the admin-
istration of yohimbine, an alpha-2 adrenoceptor antagonist that
increases noradrenaline cell firing (Aghajanian and VanderMae-
len, 1982) and enhances noradrenaline release in terminal areas
(Abercrombie et al., 1988; Pacak et al., 1992). Yohimbine induces
anxiety-like responses in both humans (Holmberg and Gershon,
1961; Bremner et al., 1996b) and laboratory animals (Bremner
et al., 1996a), and induced craving in alcohol-dependent patients
(Umhau et al., 2011). Results of the present study demonstrate
that yohimbine similarly increased alcohol-reinforced lever press-
ing in both rat lines, indicating that the polymorphism does not
seem to play a major role in stress-induced alcohol drinking. These
data were completed by the evidence that unselected Wistar rats
showed a similar outcome as the derived msP lines when chal-
lenged with yohimbine under identical experimental conditions,
a finding that closely paralleled results shown in previous studies
(Le et al., 2005; Marinelli et al., 2007). In addition, the dose of
yohimbine that increased alcohol self-administration under FR-
3 schedule (0.625 mg/kg) in all three rat lines also increased the
break point measure in all lines examined under the PR schedule,
a paradigm known to better assess motivation to obtain a drug
Frontiers in Psychiatry | Addictive Disorders and Behavioral Dyscontrol April 2013 | Volume 4 | Article 23 | 6
Ayanwuyi et al. Polymorphisms and alcohol in rats
(Arnold and Roberts, 1997). This observation suggests that spon-
taneous occurrence of the polymorphism in msP animals does not
appear to be associated with the exacerbated motivation to obtain
alcohol following stress exposure.
The effect of yohimbine on increasing alcohol consumption
shares some similarities with the effect of cycles of alcohol intoxi-
cation and withdrawal on inducing escalation of drinking (Rimon-
dini et al., 2002; O’Dell et al., 2004; Gehlert et al., 2007; Walker
and Koob, 2008; Gilpin and Koob, 2010), such that it has been
hypothesized that yohimbine- and dependence-induced increases
of operant alcohol self-administration may be mediated by sim-
ilar neurobiological mechanisms (Marinelli et al., 2007). Firstly,
both of these manipulations produce anxiety- and stress-like states
(Breese et al., 2005a; Heilig and Koob, 2007). Secondly, both
yohimbine treatment and alcohol dependence activate CRF sys-
tem in structures of the extended amygdala (Merlo Pich et al.,
1995; Zorrilla et al., 2001; Olive et al., 2002; Funk et al., 2006b;
Sommer et al., 2008), brain areas thought to mediate the neg-
ative emotional state that leads to excessive alcohol use (Heilig
and Koob, 2007; Koob, 2010; Breese et al., 2011). Lastly, antag-
onism at CRF1-R attenuates both yohimbine-induced (Marinelli
et al., 2007) and dependence-induced increases of alcohol self-
administration (Sabino et al., 2006; Chu et al., 2007; Funk et al.,
2007; Gehlert et al., 2007). The observation that antalarmin pre-
vented yohimbine-induced increase of alcohol operant responding
in Wistar rats, as well as in the alcohol-preferring msP lines
strongly supports a role of CRF-related mechanisms in the reg-
ulation of reinforcing effects of alcohol heightened by yohimbine
treatment.
When antalarmin was tested under non-stressful conditions on
the derived msP lines, the CRF1-R antagonist selectively reduced
at doses of 10 and 20 mg/kg alcohol self-administration in the
AA line, indicating that the polymorphism may confer sensitivity
to this pharmacological manipulation. This observation parallels
with what is previously shown in the original msP line where
treatment with antalarmin reduced alcohol-reinforced lever press-
ing without altering that of unselected Wistar animals (Hansson
et al., 2006). In that study, the differential effect of antalarmin
on alcohol self-administration was associated with msP upregu-
lation of CRF1-R expression and density, in turn linked to the
occurrence of the point mutations in the CRF1-R gene. Thus,
although data on CRF1-R expression or density of the AA versus
GG line are not provided in the present study, it may be hypothe-
sized that the selective reduction of operant responding for alcohol
following antalarmin treatment in the AA line is due to upregu-
lated CRF1-R function in these animals compared to the GG line.
In addition, both the unique msP genetic profile and evidence
showing that msP rats are, among other alcohol-preferring lines,
the only one sensitive to CRF1-R antagonists (Ciccocioppo et al.,
2006; Sabino et al., 2006; Gilpin et al., 2008) strongly supports
the role of the polymorphism in eliciting increased sensitivity to
the treatment with CRF1-R antagonists. Binding data on brain
CRF1-R protein expression in AA and GG rats are needed to cor-
roborate this hypothesis. Post-dependent animals were also shown
to respond to this pharmacological treatment at doses that had
no effects in non-dependent rats (Sabino et al., 2006; Chu et al.,
2007; Funk et al., 2007; Gehlert et al., 2007) to suggest that the
alcohol-dependent state recruits the CRF system. However, the
CRF1-R signaling may be also be engaged when non-dependent
animals escalate their levels of drinking (Sparta et al., 2008; Low-
ery et al., 2010; Cippitelli et al., 2012). Therefore, the reduction of
alcohol self-administration observed in Wistar rats receiving the
high dose of 20 mg/kg antalarmin is not surprising and may be due
to abnormally elevated baseline of lever pressing of the cohort of
animals employed in the present experiment. Of note, differences
in operant alcohol drinking usually observed between msP and
Wistar rats (Hansson et al., 2006; Gehlert et al., 2007) are not well
reflected here probably due to different experimental conditions
such as the use of an FR-3 reinforcement schedule. Previous stud-
ies employed an FR-1 schedule which may better reflect the rate
of consumption as it delivers reinforcement after each response
(Arnold and Roberts, 1997).
We have previously described that msP and unselected Wis-
tar rats showed differential responses when exposed to increasing
foot-shock stress intensities during extinction. Specifically, rein-
statement of Wistar rats increased progressively with shock inten-
sity while msPs reinstated responding on the previously alcohol-
associated lever after low/medium but not high shock intensities
which resulted in freezing behavior (Hansson et al., 2006). In the
present study, a similar experiment that used different doses of
yohimbine (0.625, 1.25, 2.5 mg/kg) instead of shock delivery was
conducted to assess whether the polymorphism played a role on
relapse-like behavior. Results showed that while yohimbine elicited
reinstatement throughout the range of doses examined in both
the GG line and the Wistar strain, animals carrying the polymor-
phism did not do so following injection of 2.5 mg/kg. This was
likely due to highly stressed state of these rats and suggests that
spontaneously occurring mutation at the CRF1-R gene may medi-
ate an increased vulnerability to stress and possibly, mal-adaptive
responses to intense stress exposure. MsP rats have anxiety and
depression-like traits which are congruent to clinical alcoholism.
Studies have shown that very high CRF1-R activation results in
a passive behavior in anxiety models (Zhao et al., 2007; Tovote
et al., 2010). As speculation, this inference could be extrapolated
to our results where the AA rats, due to over-activated CRF signal-
ing, were unable to reinstate responding at the highest yohimbine
dose that may be able to further engage CRF system. However,
by these data it is not possible to determine whether the poly-
morphism specifically regulates aspects of stress-induced alcohol
seeking since CRF system has been shown to play a role in the
reinstatement of various drugs of abuse (Shaham et al., 1997; Erb
et al., 1998; Zislis et al., 2007) and natural rewards (Ghitza et al.,
2006).
Alcoholism is a multi-genic disorder in which genetic predis-
position combined with environmental factors may contribute to
vulnerability to abuse. Studies have shown an association between
alcoholism and several gene polymorphisms. For example, poly-
morphisms in the serotonin 2A receptor gene, dopamine trans-
porter, µ-opioid, or GABA A receptor genes have been associated
with alcohol dependence (Oslin et al., 2003; Edenberg and Kran-
zler, 2005; Ramchandani et al., 2011; Bhaskar et al., 2012; Wrzosek
et al., 2012). In addition, recent clinical investigation has indicated
the CRF1-R locus to mediate genetic susceptibility for exces-
sive drinking (Treutlein et al., 2006). Polymorphisms in the CRF
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binding protein have also been associated with alcoholism (Enoch
et al., 2008) and severity of stress-induced alcohol craving (Ray,
2011). Overall, these results suggest that incremental advances in
treatment outcomes will result from an improved understanding
of the genetic heterogeneity among patients with alcohol addiction
that may ultimately lead to development of personalized treat-
ments (Heilig et al., 2011). The present study may add to the field
by providing evidence that spontaneously occurring mutations at
the CRF1-R locus of msP animals acquire functional relevance
leading to the expression of a particular phenotype which differs
from that of animals with a normal genetic background.
CONCLUSION
Here we show that two previously identified point mutations at the
CRF1-R gene locus do not seem to play a major role in the expres-
sion of the msP excessive drinking phenotype or stress-induced
drinking. However, their occurrence appears to be associated to an
increased sensitivity to the effects of the pharmacological blockade
of CRF1-R and to the decreased threshold for stress-induced rein-
statement of alcohol seeking behavior. Despite the fact that there is
no evidence for a correspondence of the same polymorphisms in
msP rats and human alcoholics, these findings may have important
pharmacogenetic implications because they suggest that only a
subpopulation of alcoholics, the one characterized by specific
mutation at CRF1-R gene or possibly carrying over-expression of
the CRF1-R system, may respond to CRF1-R antagonists. Nowa-
days, this consideration is particularly relevant since there are
ongoing clinical trials in which the efficacy of CRF1-R antagonists
on alcohol addiction are under exploration (Zorrilla et al., 2013).
On one hand, results of the present study may provide important
inputs to the analysis of the clinical data that will soon be available.
On the other hand, as it has already been demonstrated for naltrex-
one, a drug approved for the treatment of alcohol addiction, our
results suggest that pharmacogenetic considerations are critical for
appropriate clinical use of the agents (Heilig et al., 2011).
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